Read the latest news here...
Q3 2026 A milestone for wound closure in Belgium
A breakthrough is arriving for wound closure in Belgian operating rooms. A new product based on silk fibroin, the only wound closure solution built on this material, has received its CE marking and is preparing to enter the Belgian market.
Why this matters to every surgeon who works with wound closure on a daily basis.
The question is no longer whether silk fibroin wound closure is the future. The question is who in Belgium takes the first step.
Launch in Belgium follows in the coming weeks. More details will follow soon, stay tuned.
Orthopaedic,plastic and other surgeons who want to be among the first to discover the product can already reach out for a personal introduction or trial.
Curious what silk fibroin can mean for your practice? The invitation is open. tom@medi3s.be
Q2 2026 Something new is coming
Be prepared for a wound dressing that will redefine the way you approach wound closure. Stay tuned.
Q1 2026 New website and new logo
We have entered into a collaboration with Julie from JUBL to further optimise our website and strengthen the support we offer our customers. As part of this initiative, Julie also developed our new logo. We are proud of the result.
2025
Q4 2025 Calling surgeons: join our testing programme
We are looking for surgeons interested in testing an innovative wound dressing. Are you specialised in orthopaedics, plastic surgery, cardiovascular, gynaecological surgery or another discipline where wound closure is key? Get in touch at tom@medi3s.be
Q3 2025 A Belgian premiere is on its way
After months of close collaboration with an international manufacturer, we are proud to announce something new for Belgium. A revolutionary wound dressing based on the latest biotechnological developments. FDA approved, with CE marking confirmed in Q1 2026. More details to follow.
Q2 2025 Expanding into medical device distribution
In addition to our existing services, Medi3S now also distributes medical devices, including import services. A natural next step in our mission to bring the right solutions to the right people.
Q2 2025 MDR & GDP certified
We are pleased to announce that we successfully completed both the MDR (Medical Devices Regulation) and GDP (Good Distribution Practices) trainings. These certifications allow us to continue building the future of Medi3S, while ensuring our customers receive the highest quality, trust, and expertise.